References
- Newsom-Davis J. Neuromuscular junction channelopathies: a brief overview. Acta Neurol Belg 2005; 105: 181–6
- Mohan S, Barohn RJ, Krolick KA. Unexpected cross-reactivity between myosin and a main immunogenic region (MIR) of the acetylcholine receptor by antisera obtained from myasthenia gravis patients. Clin Immunol Immunopathol 1992; 64: 218–26
- Xiao BG, Lu CZ, Hojeberg B, Link H. Immunological specificity and cross-reactivity of anti-acetylcholine receptor and anti-presynaptic membrane receptor antibodies in myasthenia gravis. J Neurol Sci 1991; 105: 118–23
- Verschuuren JJ, Graus YM, Tzartos SJ, van Breda Vriesman PJ, De Baets MH. Paratope- and framework-related cross-reactive idiotopes on anti-acetylcholine receptor antibodies. J Immunol 1991; 146: 941–8
- Mappouras DG, Philippou G, Haralambous S, Tzartos SJ, Balafas A, Souvatzoglou A, Lymberi P. Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves's disease. Clin Exp Immunol 1995; 100: 336–43
- Roberts A, Lang B, Vincent A, Newsom-Davis J. Search for cross-reactive idiotypes on monoclonal and myasthenia gravis acetylcholine-receptor antibodies. Autoimmunity 1992; 12: 53–60
- Tzartos SJ, Remoundos M. Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients. Clin Exp Immunol 1999; 116: 146–52
- Deitiker P, Ashizawa T, Atassi MZ. Antigen mimicry in autoimmune disease. Can immune responses to microbial antigens that mimic acetylcholine receptors act as initial triggers of myasthenia gravis?. Hum Immunol 2000; 61: 255–65
- Dyrberg T, Petersen JS, Oldstone MB. Immunological cross-reactivity between mimicking epitopes on a virus protein and a human autoantigen depends on a single amino acid residue. Clin Immunol Immunopathol 1990; 54: 290–7
- Howard FM, Jr, Lennon VA, Finley J, Matsumoto J, Elveback LR. Clinical correlations of antibodies that bind, block, or modulate human acetylcholine receptors in myasthenia gravis. Ann N Y Acad Sci 1987; 505: 526–38
- Staines DR. Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders. Med Hypotheses 2005; 65: 797–803
- Finsterer J, Oberman I, Reitner A. Respiratory chain complex-I defect mimicking myasthenia. Metab Brain Dis 2002; 17: 41–6